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Abstract
Plasmodium falciparum causes the most virulent form of malaria and encodes a large number of molecular chaperones.
Because the parasite encounters radically different environments during its lifecycle, many members of this chaperone
ensemble may be essential for P. falciparum survival. Therefore, Plasmodium chaperones represent novel therapeutic
targets, but to establish the mechanism of action of any developed therapeutics, it is critical to ascertain the functions of
these chaperones. To this end, we report the development of a yeast expression system for PfHsp70-1, a P. falciparum
cytoplasmic chaperone. We found that PfHsp70-1 repairs mutant growth phenotypes in yeast strains lacking the two
primary cytosolic Hsp70s, SSA1 and SSA2, and in strains harboring a temperature sensitive SSA1 allele. PfHsp70-1 also
supported chaperone-dependent processes such as protein translocation and ER associated degradation, and ameliorated
the toxic effects of oxidative stress. By introducing engineered forms of PfHsp70-1 into the mutant strains, we discovered
that rescue requires PfHsp70-1 ATPase activity. Together, we conclude that yeast can be co-opted to rapidly uncover
specific cellular activities mediated by malarial chaperones.
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Introduction
Malaria is a major worldwide health concern, infecting
approximately 250 million people and killing at least one million
people annually. Most of those killed by malaria are children. The
diseasedisproportionately affects individuals inSub-SaharanAfrica,
as well as in Asia, Latin America, the Middle East and parts of
Europe. Malaria is caused by a protozoan infection, and Plasmodium
falciparum is the most common and deadly species in the malarial
parasite family. Unfortunately, the emergence of drug resistant
malarial strains has made the disease significantly more difficult to
treat. Widespread resistance to affordable and formerly effective
drugs like chloroquine, which inhibits heme detoxification [1], has
been well documented. Resistance to artemenisin combination
therapies, which was once thought to provide a fail-safe treatment
option, has now been documented along the Thai-Cambodian
border [2]. Other new antimalarials are prohibitively expensive
and/or are accompanied by adverse side effects [3]. Overall, it is
critical that novel drug targets are identified and that the
mechanism of action of putative new anti-malarials [2] are defined
so that compounds with improved efficacy can be developed.
One new anti-malarial target is molecular chaperones. Molec-
ular chaperones are defined as proteins that prevent aberrant
interactions between macromolecules. As a result, this broad class
of highly conserved factors prevents protein aggregation and
facilitates a number of cellular processes, including protein
transport, assembly, disassembly, and degradation [4]. Heat shock
proteins, a group of molecular chaperones first identified by their
increased expression during temperature stress [5], are classified
by molecular mass. One class, the 70 kDa heat shock proteins,
Hsp70s, have an N-terminal ATP-binding domain followed by a
substrate-binding domain (SBD); the SBD contains a pocket to
bind hydrophobic regions in substrates [6,7]. A C-terminal lid
entraps peptide substrates. In order to drive cycles of substrate
binding and release, Hsp70s hydrolyze ATP: Hsp70s exhibit a low
affinity and high off-rate for peptides in the ATP bound state, but
they exhibit high affinity binding and a low off-rate in the ADP
bound state. The release of bound ADP, and subsequent rebinding
to ATP, requires at least one member of an emerging class of
structurally diverse nucleotide exchange factors [8].
Hsp40s are another abundant and conserved family of
molecular chaperones [9,10]. Although Hsp40s can bind directly
to hydrophobic regions of unfolded protein substrates [11], and
are consequently bona fide molecular chaperones in isolation, they
most often function as Hsp70 co-chaperones. Notably, Hsp40s
stimulate the rate of ATP hydrolysis by Hsp70s and thus facilitate
the binding of Hsp70s to their substrates. Therefore, the
coordinated action of Hsp70s with select Hsp40 partners provides
enhanced chaperone activity.
There are several reasons why heat shock protein studies in the
malarial parasite are of great importance. The genome of P.
falciparum contains sequences encoding six Hsp70s and forty-three
Hsp40s [12,13]; this large number of Hsp70s and Hsp40s in a
parasite suggests that the chaperones might be crucial for survival
[14,15]. Furthermore, features of the parasite’s lifecycle suggest a
profound requirement for molecular chaperone function, and in
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mosquitoes that live in ambient temperature, but the parasite then
replicates in humans at 37uC and must endure temperature stresses
during the episodes of fever that result from infection [16]. Second,
the parasite is exposed to an oxidative stress when harbored within
red blood cells [17], and Hsp70-Hsp40 function is known to
mitigate the cellular toxicity that is triggered by oxidatively
damaged proteins [18]. Third, during infection, P. falciparum
establishes a unique secretory pathway within infected red blood
cells. Given the many connections between Hsp70 and Hsp40
function and the secretory pathway in eukaryotes [19], these heat
shock proteins might reorganize organelles within the parasite that
constitute the Plasmodium-specific secretory pathway [20]. Fourth,
the secretion of one Hsp40 homolog is required for the formation of
‘‘knobs’’ on infected red blood cells, which enables the parasite to
survive by avoiding the splenic filtration system [21]. Finally,
15-deoxyspergualin, a compound that modulates Hsp70 activity
[22–24],inhibitsthegrowthofP.falciparumbyalteringproteintraffic
to the parasite’s apicoplast [25–27].
Of late, there has been an increased desire to develop
therapeutics that target chaperone function, in particular the
function of Hsp70s [28,29]. However, in parallel, it is vital to
define the potentially unique in vivo activities of Hsp70s. In most
cell types, this is a straight-forward procedure. Unfortunately,
genetic manipulations of P. falciparum are cumbersome, the
development of biochemical assays in this organism suffer from
difficulties in preparing large amounts of starting material, and
few tools are available to probe the functions of malarial gene
products in vivo. To surmount these technical hurdles, we
developed a malarial Hsp70 expression system in another
eukaryote, the yeast Saccharomyces cerevisiae. Heterologous yeast
expression systems have been used to define the etiology of
numerous human diseases, and genetic manipulations are facile.
Moreover, a large number of tools have been developed to dissect
Hsp70 function in vivo. Finally, yeast expression and complemen-
tation studies have been used to explore the properties of several
chaperones from other organisms (see for example [30–36]). The
data presented in this manuscript indicate that a malarial
chaperone, PfHsp70-1, facilitates many of the same Hsp70-
dependent activities documented in other eukaryotes. Our study
also sets-the-stage to define the activities of additional P.
falciparum-encoded molecular chaperones [37,38].
Table 1. Yeast Strains used in this study.
Strain Genotype Reference or Source
BY4742 MATa, his3D1, leu2D0, lys2D, ura3D0 Research Genetics
SSA1 ssa2D ssa3D ssa4D MATa, his3-11,15, leu2-3,112, ura3-52, trp1-1, lys2, SSA1, ssa2-1::LEU2, ssa3-1::TRP1, ssa4-2::LYS2 [47]
ssa1-45 ssa2D ssa3D ssa4D MATa, his3-11,15, leu2-3,112, ura3-52, trp1-1, lys2, ssa1-45, ssa2-1::LEU2, ssa3-1::TRP1, ssa4-2::LYS2 [47]
SSA1 SSA2 MATa, kar1-1, SUQ5, ade2-1, his3D202, leu2D1, trp1D63, ura3-52, ura2::KanMX [59]
ssa1D ssa2D MATa, kar1-1, SUQ5, ade2-1, his3D202, leu2D1, trp1D63, ura3-52, ura2::KanMX, ssa1::KanMX, ssa2::HIS3 [59]
doi:10.1371/journal.pone.0020047.t001
Table 2. Yeast Expression Plasmids used in this study.
Plasmid Genotype Reference or source
pQE30-PfHsp70 Amp
R,2 m, PfHsp70-1 [42]
p426GPD-(His)6-SSA1 Amp
R, URA3, 2m, SSA1 [41]
p416TEF Amp
R, URA3, CEN [39]
p414TEF Amp
R, TRP1, CEN [39]
pRS313 Amp
R, HIS3, CEN [40]
p416-PSSA1 Amp
R, URA3, CEN, PSSA1 this study
p416-PSSA1-SSA1 Amp
R, URA3, CEN, PSSA1, SSA1 this study
p416-PSSA1-PfHsp70-1 Amp
R, URA3, CEN, PSSA1, PfHsp70-1 this study
p416-PSSA1-PfHsp70-1-G214D Amp
R, URA3, CEN, PSSA1, PfHsp70-1-G214D this study
p416-PSSA1-PfHsp70-1-P434L Amp
R, URA3, CEN, PSSA1, PfHsp70-1-P434L this study
p414-PSSA1 Amp
R, TRP1, CEN, PSSA1 this study
p414-PSSA1-SSA1 Amp
R, TRP1, CEN, PSSA1, SSA1 this study
p414-PSSA1-PfHsp70-1 Amp
R, TRP1, CEN, PSSA1, PfHsp70-1 this study
p414-PSSA1-PfHsp70-1-G214D Amp
R, TRP1, CEN, PSSA1, PfHsp70-1-G214D this study
p414-PSSA1-PfHsp70-1-P434L Amp
R, TRP1, CEN, PSSA1, PfHsp70-1-P434L this study
p313-PSSA1 Amp
R, HIS3, CEN, PSSA1 this study
p313-PSSA1-SSA1 Amp
R, HIS3, CEN, PSSA1, SSA1 this study
p313-PSSA1-PfHsp70-1 Amp
R, HIS3, CEN, PSSA1, PfHsp70-1 this study
pRS426-CFTR-HA Amp
R, URA3, 2m, CFTR-3xHA [46]
doi:10.1371/journal.pone.0020047.t002
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PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e20047Figure 1. S. cerevisiae Hsp70, Ssa1, and P. falciparum Hsp70, PfHsp70-1, are .70% identical. The alignment was generated using ClustalW2
software [70]. Sequences in bold face indicate identity, and underlined sequences indicate similarity. Gaps are indicated with a dash. Asterisks denote
amino acids substituted in the PfHsp70-1 mutants (see text for details).
doi:10.1371/journal.pone.0020047.g001
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Construction of Yeast Expression Vectors for the P.
falciparum Hsp70, PfHsp70-1, and for the Yeast Hsp70, Ssa1
Yeast strains and expression plasmids used in this study are
listed in Table 1 and Table 2, respectively. Yeast expression
vectors for PfHsp70-1 were constructed using the SSA1 endoge-
nous promoter and single copy number plasmids. The following
primers were designed in order to PCR amplify the SSA1
promoter, which includes the 500 bp untranslated region directly
upstream of the SSA1 gene: 59–CTA GAG GAT CCA TGT CAA
AAG CTG TCG GTA–39 and 59–CAG TTC AAG CTT TTA
ATC AAC TTC TTC AAC GG–39. SacI and BamHI restriction
sites, respectively, were engineered into these primers (underlined)
to facilitate subsequent cloning, and genomic DNA from a wild
type yeast strain was used as a template in the PCR reaction. The
amplified SSA1 promoter was gel purified and subcloned into three
CEN/ARS yeast expression plasmids; the SSA1 promoter replaced
the TEF promoter in the p416TEF and p414TEF plasmids, and
the SSA1 promoter was inserted into pRS313 between the SacI
and BamHI restriction sites [39,40]. This generated the ‘‘empty’’
expression vectors p416-PSSA1, p414-PSSA1, and p313-PSSA1, which
were used as negative controls in our experiments. Next, to
construct plasmids for the expression of Ssa1 and PfHsp70-1,
plasmids containing the SSA1 [41] or PfHsp70-1 [42] genes were
digested with BamHI and HindIII, and the excised genes were
ligated into the empty vectors, indicated above, using the BamHI
and HindIII restriction sites. This yielded the plasmids p416-PSSA1-
SSA1, p414-PSSA1-SSA1, p313-PSSA1-SSA1, p416-PSSA1-PfHsp70-1,
p414-PSSA1-PfHsp70-1, p313-PSSA1-PfHsp70-1. The plasmids were
verified using restriction digest and DNA sequence analysis.
PfHsp70-1 mutants were generated using the QuikChange
Mutagenesis kit (Stratagene). The p416-PSSA1-PfHsp70-1 plasmid
was used as a template, and the following primer pairs were used to
introduce the G214D and P434L substitutions, respectively
(underlined sequence indicates mutated sequence): 59–CAT TTT
AAT TTT CGA CTT AGG AGA TGG TAC ATT TGA TGT
ATC ATT AT–39 and 59–ATA ATG ATA CAT CAA ATG TAC
CAT CTC CTA AGT CGA AAA TTA AAA TG–39;5 9–ATT
GAA AGA AAC ACA ACC ATA CTA GCT AAA AAG AGT
CAA ATC TTT AC–39 and 59–GTA AAG ATT TGA CTC TTT
TTA GCT AGT ATG GTT GTG TTT CTT TCA AT–39. The
desired mutations in the resulting p416-PSSA1-PfHsp70-1-G214D
and p416-PSSA1-PfHsp70-1-P434L constructs were confirmed by
DNA sequence analysis, and the genes were cloned into the
p414TEF plasmid using the SacI and XhoI restriction sites, giving
plasmids p414-PSSA1-PfHsp70-1-G214D and p414-PSSA1-PfHsp70-1-
P434L. These constructs were verified using restriction digest.
Yeast Molecular and Biochemical Techniques
Lithium acetate transformation [43] was used to introduce the
desired plasmids into the indicated yeast strains. Cells were grown
at 26uC unless indicated otherwise, and in the indicated selective
media supplemented with 2% glucose [44]. Where noted, cells
were grown in the presence of cadmium chloride (Sigma), copper
sulfate (Sigma), diamide (Sigma), or hydrogen peroxide (TopCare)
at the indicated concentrations.
The solubility of PfHsp70-1 expressed in yeast was assessed as
described [45] with minor modifications. Equivalent numbers of
cells (,10 OD600 units of cells) were harvested and then lysed with
glass beads in 20 mM HEPES, pH 7.4, 100 mM NaCl, 20 mM
MgCl2, and a protease inhibitor cocktail. The cleared lysates were
centrifuged at 16,000 g for 15 min at 4uC and the resulting
supernatant and pellet fractions were collected and analyzed by
SDS-PAGE. The presence of soluble PfHsp70-1 in the superna-
tant was examined by western blot analysis.
Endoplasmic reticulum associated degradation (ERAD) effi-
ciency was measured through a cycloheximide chase assay using
the cystic fibrosis transmembrane conductance regulator as a
substrate for this pathway [46]. In brief, cycloheximide chase
analyses were performed by growing yeast cells to logarithmic
phase (OD600=0.5–1.2) in selective media at 30uC. Cyclohexi-
mide was added to a final concentration of 100 mg/ml, the cells
were shifted to 37uC, and aliquots of ,1O D 600 units of cells were
harvested at the indicated times. Proteins were isolated using
trichloroacetic acid (TCA) precipitation, and western blot analysis
was used to detect the indicated protein substrates. The stability of
PfHsp70-1 was measured using the same method except that the
appropriate antibody was used (see below).
Defects in prepro-afactor (ppaF) translocation [41] were assessed
by growing cells to logarithmic phase (OD600=0.5–1.2) at 26uC
and shifting the cultures to 37uC for 15 min to induce the ssa1
mutant phenotype [47]. The cells were then harvested (,3O D 600
units of cells) and resuspended in sample buffer (80 mM Tris,
pH 6.8, 2% sodium dodecyl sulfate, 0.1% bromophenol blue,
100 mM dithiotreitol, 10% glycerol). After incubating samples at
Figure 2. PfHsp70-1 is stable and soluble when expressed in S.
cerevisiae. (A) A cycloheximide chase analysis was performed using a
wild type yeast strain transformed with plasmid p416-PSSA1-PfHsp70-1
(top) or p416-PSSA1- SSA1 (bottom). The assay was performed at 30uC,
and samples were taken at the indicated time points after the addition
of cycloheximide. Samples were processed as described in the
‘‘Methods’’. (B) Cells expressing PfHsp70-1 were lysed and processed
as described in the ‘‘Methods’’. Sec61 was probed as an ER membrane
protein control and G6PDH was probed as a soluble (cytosolic) protein
control. L: lysate; S, soluble fraction; P, pellet fraction. Please note that
the lysate examined in this panel represents only a variable fraction of
the total lysate that was processed to obtain the soluble and pellet
samples.
doi:10.1371/journal.pone.0020047.g002
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analysis was then used to detect the untranslocated substrate, ppaF,
using a specific anti- ppaF antibody that was a kind gift from R.
Schekman (University of California, Berkeley).
Other antibodies used for these studies included anti-PfHsp70-1
[42], anti-Ssa1 [48], anti-Sec61 [49], anti-glucose-6-phosphate
dehydrogenase (G6PDH) (Sigma), and horseradish peroxidase-
conjugated anti-haemaglutinin-A (Sigma). Western blots were
imaged using enhanced chemiluminescence (Pierce) and a Kodak
440CF Image Station and the resulting data were quantified using
Kodak 1D software (Eastman Kodak).
Results
The Malarial Hsp70 homologue, PfHsp70-1, can be
expressed and is stable in the yeast, S. cerevisiae
To examine whether the function of a malarial chaperone could
be studied in another eukaryote that might be more amenable to
molecular and genetic tools, we selected the P. falciparum Hsp70-1
protein for the following reasons. Most importantly PfHsp70-1 has
been shown to be expressed in the parasite and can function as a
chaperone in vitro [42,50,51]. In addition, the protein ends in an
EEVD motif. This amino acid sequence is required for Hsp70 to
interact with tetratricopeptide repeat domain-containing proteins,
which are found in many Hsp70 co-chaperones and play an
important role in cellular physiology in eukaryotes [52].
Furthermore, evidence exists for an interaction between
PfHsp70-1 and a parasitic Hsp40 homolog [51], suggesting that
PfHsp70-1 has the ability to interact with co-chaperones. And
finally, a role for P. falciparum Hsp70s in protein transport has been
inferred [53], suggesting that Hsp70-1 might functionally
substitute for a yeast Hsp70 homolog that is similarly required
for protein transport.
Next, we generated yeast expression plasmids for the malarial
chaperone. The PfHsp70-1 gene was subcloned and placed under
the transcriptional control of a promoter for a yeast Hsp70, Ssa1,
Figure 3. Expression of PfHsp70-1 in the ssa1-45 and ssa1Dssa2D mutants partially complements the temperature sensitive
phenotype and rescues the null phenotype. The indicated yeast strains were transformed with the designated plasmids, grown to log phase,
and serially diluted on selective media and incubated at the noted temperatures for 2–3 d. The images shown are representative of at least three
independent experiments, all demonstrating the same phenomena. ‘‘-’’ indicates an empty vector control.
doi:10.1371/journal.pone.0020047.g003
Figure 4. Expression of PfHsp70-1 in an ssa1Dssa2D mutant partially rescues sensitivity to oxidative stress. The indicated yeast strains
transformed with the designated plasmids were grown to log phase, serially diluted, and plated on selective media in the absence of any additives or
with the indicated amount of a stress-inducing agent. The plates were imaged after 2–3 d growth at 26uC. The images shown are representative of at
least three independent experiments, all demonstrating the same phenomena. ‘‘-’’ indicates an empty vector control.
doi:10.1371/journal.pone.0020047.g004
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under the same transcriptional control as the yeast chaperone and
respond to the same cellular stress conditions. In addition,
PfHsp70-1 and Ssa1 are 71% identical and 97% similar
(Figure 1). The sequence identity is even higher in the ATPase
domain and critical residues required for this enzymatic activity
are identical between PfHsp70-1 and Ssa1; this feature is critical
for the interpretation of mutagenesis studies (see below). SSA1
encodes a constitutively expressed cytosolic Hsp70 in yeast and the
gene is only mildly induced by heat shock [54]. Moreover, Ssa1 is
required during the post-translational translocation of newly
synthesized secreted proteins into the endoplasmic reticulum
(ER) [47,55,56], and for the ER associated degradation (ERAD) of
misfolded membrane proteins such as the cystic fibrosis trans-
membrane conductance regulator (CFTR) [46,57]. Consequently,
there are a number of assays that can be co-opted to assess
PfHsp70-1 function. As a positive control for these studies, we also
cloned SSA1 into the same single-copy expression vector, and as a
negative control, the SSA1 promoter was cloned into the plasmid
but a downstream gene was absent.
In addition to SSA1, S. cerevisiae harbors genes for the expression
of three additional members of this cytosolic Hsp70 family [54].
Ssa2 is also constitutively expressed and is 98% identical to Ssa1.
In contrast, Ssa3 and Ssa4 are poorly expressed but are highly
stress inducible. Therefore, the function of Ssa1, or any
heterologously expressed Hsp70, is best studied in the ssa1-45
strain [47]. This strain contains a copy of SSA1 with a point
mutation that renders Ssa1 inactive at temperatures above 37uC,
and both the mutant and isogenic ‘‘wild type’’ strains have the
remaining three SSA genes—SSA2, SSA3, and SSA4—deleted to
prevent their ability to complement the ssa1-45 allele due to
functional redundancy. As a second approach to probe PfHsp70-1
Figure 5. Mutations in the ATPase domain and in the SBD subvert the PfHsp70-1-mediated improvement of growth in the ssa1-45 or
ssa1Dssa2D mutants. (A) The indicated mutant strains transformed with the designated plasmids were grown to log phase, serially diluted, and
plated on selective media and incubated at the indicated temperatures for 2–3 d. (B) Cells were plated on selective media containing the indicated
stress-inducing agent, grown at 26uC, and imaged after 3 d. In both panels, the images shown are representative of at least three independent
experiments, all demonstrating the same phenomena. ‘‘-’’ indicates an empty vector control.
doi:10.1371/journal.pone.0020047.g005
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for growth and has been used to analyze the contributions of
Hsp70 chaperones on various cellular processes [54,58–61].
We next verified the stable expression of the PfHsp70-1 in yeast
by transforming a wild strain, BY4742 (Table 1), with the SSA1
expression vector and the PfHsp70-1expression vector. To examine
thecomparative stabilitiesofthetwoHsp70s,a cycloheximide chase
analysis was performed. Figure 2A shows that PfHsp70-1 is as stable
as the endogenous yeast homolog, Ssa1. To ensure that the
heterologously expressed protein is also soluble, cells expressing the
proteins were lysed and cytosolic fractions wereprepared. Figure 2B
shows that PfHsp70-1 remains soluble when expressed in yeast.
PfHsp70-1 partially rescues the temperature sensitivity
and oxidative stress of yeast deficient in cytoplasmic
Hsp70 function
Because Ssa1 and PfHsp70-1 are 71% identical (Figure 1), and
because PfHsp70-1 is stable and soluble when expressed in yeast,
we next examined whether PfHsp70-1 can rescue the thermo-
sensitivity of ssa1-45 yeast. The wild type and mutant strains were
transformed with an ‘‘empty’’ vector and with the vectors
engineered for Ssa1 or PfHsp70-1 expression. The transformants
were serially diluted, plated on selective media, and grown at
various temperatures. As shown in Figure 3A, the SSA1 wild type
strain grew robustly at all temperatures regardless of the
introduced plasmid; therefore, PfHsp70-1 does not impart a
negative effect on cell growth. In contrast, the ssa1-45 strain with
the empty vector grew poorly at elevated temperatures. As
expected, however, when this mutant harbored a plasmid-borne
wild type copy of SSA1, temperature sensitivity was rescued. When
ssa1-45 expressed PfHsp70-1, temperature sensitivity was rescued
under all conditions except at the very highest temperature
examined. These data indicate that PfHsp70-1 substitutes for Ssa1
function in yeast under most growth conditions.
The growth of ssa1Dssa2D yeast, along with the isogenic wild
type strain, was also examined when the PfHsp70-1 or Ssa1
expression vectors or the empty vector control were introduced.
The transformed wild type and mutant strains were again serially
diluted, plated on selective media, and propagated at various
temperatures. As shown in Figure 3B, the ssa1Dssa2D mutant
transformed with an empty vector grew poorly at higher
temperatures, but again, as expected, expression of wild type
Ssa1 rescued temperature sensitivity. Expression of PfHsp70-1 also
rescued growth at 34uC, but failed to rescue temperature
sensitivity at 37uC. These data are consistent with the level of
rescue observed in Figure 3A.
Because P. falciparum must thrive under oxidative conditions, and
because chaperone function in cells is critical under these conditions
(see Introduction), we next studied the ability of PfHsp70-1 to
restore Ssa1-dependent growth in yeast exposed to oxidative
stressors. The ssa1Dssa2D and the isogenic wild type strains
transformed with the PfHsp70-1 and Ssa1 expression vectors and
an empty vector were dilutedand grown on mediacontainingeither
cadmium chloride, copper sulfate, diamide, or hydrogen peroxide,
each of which is known to induce an oxidative stress [62]. For
example, cadmium and copper catalyze the formation of reactive
oxygen species. Cadmium also causes a nonspecific stress in cells. In
contrast, diamide oxidizes glutathione reductase, preventing the cell
from eliminating reactive oxygen species, and hydrogen peroxide
directly introduces reactive oxygen species in the cell.
As shown in Figure 4, ssa1Dssa2D growth at 26uC is severely
affected inthe presenceofeachoftheseoxidativestressors;however,
when ssa1Dssa2D cells express Ssa1, the growth defect is absent.
Expression of PfHsp70-1 in ssa1Dssa2D yeast also rescued the
growth defect on oxidative agents, although to a somewhat lesser
extent than did the expression of Ssa1. Therefore, PfHsp70-1 at
least partially supplants Ssa1 function during oxidative stress.
PfHsp70-1 rescue requires conserved amino acid residues
critical for chaperone function
In theory, the partialrescue observed uponPfHsp70-1expression
could have arisen from the expression of other complementing
chaperones. For example, the expression of a foreign protein, such
as PfHsp70-1, could induce a stress response, which in turn might
Figure 6. Ssa1 is not upregulated in response to wild type or mutant PfHsp70-1 expression. The indicated yeast strains transformed with
the indicated plasmids were grown in liquid culture to log phase at 26uC and were then incubated at 37uC for 30 min. Equivalent amounts of cells
were harvested, and samples were processed as described in the ‘‘Methods’’. Note: The anti-Ssa1 antiserum crossreacts with Ssa3 and/or Ssa4, since
there is a faint band in the ssa1Dssa2D strain transformed with the empty vector. This antiserum recognizes the last 56 amino acids in Ssa1 (E. Craig,
personal communication). Also note that the levels of the PfHsp70-1 mutants are similar to the level of the wild type protein (compare the last three
lanes, top-right panel). The absence of an increased level of Ssa1 in ssa1-45 yeast containing the SSA1 expression vector most likely results from the
fact that the protein binds to its message and represses translation [71]. Thus, the expression of Ssa1 is expected to depress both its own synthesis
and the synthesis of the Ssa1-45 mutant protein.
doi:10.1371/journal.pone.0020047.g006
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two lines of investigation. First, we generated PfHsp70-1 mutants
that are predicted to disable Hsp70 function. One mutation, P434L,
is the equivalent mutation found in ssa1-45, and resides in the
substrate-binding domain of the Hsp70 [47]. The second mutation,
G214D, is in the ATPase domain of the Hsp70 and inhibits ATP
hydrolysis [41], thereby disabling the chaperone. These two
mutated residues, marked with asterisks in Figure 1, are conserved
from E. coli to mammals.
When the ssa1-45 and ssa1Dssa2D strains expressed these mutant
forms of PfHsp70-1, we found that the strains remained thermo-
sensitive (Figure 5A). In addition, the oxidative sensitivity of
ssa1Dssa2D yeast was unaffected when the PfHsp70-1 mutants were
expressed (Figure 5B). When these mutant forms of PfHsp70-1 were
expressed in the wild type strains, no growth defect was observed, so
the PfHsp70-1 mutants do not negatively affect growth (data not
shown).
As a second approach to establish that the rescue conferred by
PfHsp70-1 expression was specific, we measured the levels of Ssa1
in each of the examined strains. As shown in Figure 6, Ssa1 is not
upregulated in a PfHsp70-1-dependent manner. Together, these
data strongly suggest that PfHsp70-1 specifically rescues growth
defects associated with ssa1 mutant alleles.
PfHsp70-1 also repairs cellular events that are
compromised in ssa1 mutant yeast
As described in the Introduction, Ssa1 directly catalyzes various
processes, including protein translocation into the ER and the ER
associated degradation (ERAD) of misfolded membrane proteins.
Previous studies that uncovered these phenomena utilized the ssa1-
45 strain [46,47,63]. Therefore, we measured the ability of
PfHsp70-1 to repair protein translocation and ERAD defects in
the ssa1-45 mutant and compared the effects when this strain
contained either a vector control or an exogenous copy of SSA1.
Figure 7. PfHsp70-1 partially restores translocation and ERAD efficiencies in the ssa1-45 mutant. (A) The indicated transformed strains
were grown to log phase at 26uC, and were then incubated at 37uC for 15 min. Equal amounts of cells were harvested and processed as described in
the ‘‘Methods’’. The graph shows the relative accumulation of ppaF. The accumulation of ppaF in the ssa1-45 strain transformed with an empty
vector was set to 1 (i.e., maximal accumulation of ppaF). Error bars indicate SEM, n=4 independent experiments, and statistical significance was
calculated using a Student’s t-test; * denotes p,0.05, and ** denotes p,0.005. (B) ERAD was examined using cycloheximide chase analyses as
described in the ‘‘Methods’’. The percent CFTR remaining over time was calculated for ssa1-45 transformed with an empty vector (#), an Ssa1
expression vector (N), or a PfHsp70-1 expression vector (n). CFTR degradation in the wild type SSA1 strain was identical to that of ssa1-45 transformed
with the Ssa1 expression vector (data not shown). Error bars depict the SEM, n$4, and statistical significance was calculated using a Student’s t-test; *
denotes p,0.05.
doi:10.1371/journal.pone.0020047.g007
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decreased the amount of untranslocated ppaF that accumulated in
ssa1-45 yeast (Figure 7A). Second, we found that the degradation
of CFTR, an integral membrane protein that serves as an ERAD
substrate in yeast [46], was accelerated upon the expression of
PfHsp70-1 in the ssa1-45 strain (Figure 7B). Together, these data
indicate that PfHsp70-1 repairs specific Hsp70-dependent activ-
ities that are defective in ssa1 yeast.
Discussion
The purpose of this study was to design a yeast-based expression
system to characterize the function of the P. falciparum Hsp70,
PfHsp70-1. To this end, expression plasmids were constructed in
which the endogenous promoter for the yeast cytosolic Hsp70,
Ssa1, controlled the production of PfHsp70-1. In parallel, an Ssa1
expression vector under the control of its own promoter was used.
Our combined data indicate that PfHsp70-1 partially restores
several well-characterized Hsp70-mediated activities in ssa1
mutant cells. More generally, our results indicate that the function
of PfHsp70-1 can be studied in a new, genetically tractable
eukaryotic system, and suggest strongly that PfHsp70-1 performs
housekeeping chaperone functions in the malarial parasite,
P. falciparum.
It is important to place our findings in the context of a previous
study in which the ability of PfHsp70-1 to replace the E. coli
Hsp70, DnaK, was examined [64]. It was found that high-level
expression of PfHsp70-1 rescued the temperature sensitive growth
phenotype of strains with mutations in DnaK, but PfHsp70-1
failed to restore growth in a DnaK deleted strain at high
temperature. Cellular functions associated with DnaK activity
were not examined. However, by constructing DnaK-PfHsp70-1
chimeras, Blatch and colleagues discovered that the SBD of
PfHsp70-1 was critical for improved thermotolerance. This result
suggests that the range of peptides bound by an Hsp70 chaperone
is important to maintain viability. In our study, we again examined
the ability of an evolutionary distant chaperone to function in a
genetic system. But, we purposely chose to employ a genetically
amenable eukaryote so that compartment-specific phenotypes
could be assessed (i.e., ERAD and translocation), as well as more
general responses (i.e., thermosensitivity and oxidative stress).
Does P. falciparum Hsp70 represent a potential target to identify
novel antimalarial agents, and might our yeast expression system
be employed to identify these compounds? Yeast have long been
used for high throughput screening efforts [65]. However, it is not
clear whether potent inhibitors could be identified that selectively
block the action of PfHsp70-1 but leave the human host’s Hsp70
untouched. Some progress toward this goal has been achieved
[66,67]. Nevertheless, even if an Hsp70 inhibitor compromised the
function of both human and P. falciparum Hsp70, examples are
known in which modest depletion of Hsp70 inhibits the growth of
an unwanted cell-type, such as a cancer cell, but has no effect on
normal cells [68]. In addition, the partial inhibition of another
chaperone, Hsp90, has been shown to sensitize pathogenic yeast to
antibiotics [69]. Therefore, we suggest that partial inhibition of
Hsp70 may potentiate the effects of established antimalarial drugs.
This effect might be particularly robust during fever, when the
levels of P. falciparum Hsp70 and Hsp40 rise in order to maintain
parasite homeostasis [15,38,67]. In fact, a compound that targets
both Hsp70 and Hsp90 has been shown to inhibit protein
trafficking and the growth of P. falciparum in red blood cells
[25–27].
Based on the development of this new system, we can now
examine the functions of other cytosolic Hsp70s from P. falciparum
in ssa1 yeast. Moreover, we can examine the function of parasitic
Hsp70s that reside in organelles, for example the ER or
mitochondria, in yeast strains lacking functional versions of the
analogous organellar chaperone(s). Given the large number of
Hsp70 homologs in the malarial parasite, and near absence of
information on their activities, we are confident that these efforts
will prove worthwhile in future efforts.
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